Molecular Diagnosis of Cancer

We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. These drugs are only the forerunners of a coming tidal wave of novel therapeutics that individually target specific m- ecules within cancer cells-more than 300 such agents are currently in phase I or II clinical trials.